Two Sigma Advisers’s Aurinia Pharmaceuticals AUPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Buy |
178,000
+50,000
| +39% | +$424K | ﹤0.01% | 1254 |
|
|
2025
Q1 | $1.03M | Buy |
+128,000
| New | +$1.03M | ﹤0.01% | 1460 |
|
|
2024
Q1 | – | Sell |
-149,900
| Closed | -$1.35M | – | 2454 |
|
|
2023
Q4 | $1.35M | Sell |
149,900
-433,000
| -74% | -$3.89M | ﹤0.01% | 1485 |
|
|
2023
Q3 | $4.53M | Sell |
582,900
-177,200
| -23% | -$1.38M | 0.01% | 791 |
|
|
2023
Q2 | $7.36M | Buy |
760,100
+471,800
| +164% | +$4.57M | 0.02% | 604 |
|
|
2023
Q1 | $3.16M | Buy |
288,300
+209,100
| +264% | +$2.29M | 0.01% | 1025 |
|
|
2022
Q4 | $342K | Buy |
79,200
+15,000
| +23% | +$64.8K | ﹤0.01% | 2021 |
|
|
2022
Q3 | $483K | Buy |
+64,200
| New | +$483K | ﹤0.01% | 1853 |
|
|
2020
Q4 | – | Sell |
-56,800
| Closed | -$837K | – | 2385 |
|
|
2020
Q3 | $837K | Sell |
56,800
-30,400
| -35% | -$448K | ﹤0.01% | 1585 |
|
|
2020
Q2 | $1.42M | Buy |
87,200
+13,400
| +18% | +$218K | ﹤0.01% | 1402 |
|
|
2020
Q1 | $1.07M | Buy |
+73,800
| New | +$1.07M | ﹤0.01% | 1449 |
|
|
2019
Q2 | – | Sell |
-10,900
| Closed | -$71K | – | 2307 |
|
|
2019
Q1 | $71K | Buy |
+10,900
| New | +$71K | ﹤0.01% | 2216 |
|
|
2018
Q3 | – | Sell |
-25,900
| Closed | -$146K | – | 2228 |
|
|
2018
Q2 | $146K | Sell |
25,900
-12,000
| -32% | -$67.6K | ﹤0.01% | 2240 |
|
|
2018
Q1 | $197K | Sell |
37,900
-10,500
| -22% | -$54.6K | ﹤0.01% | 2152 |
|
|
2017
Q4 | $219K | Sell |
48,400
-7,100
| -13% | -$32.1K | ﹤0.01% | 2059 |
|
|
2017
Q3 | $348K | Buy |
55,500
+8,900
| +19% | +$55.8K | ﹤0.01% | 1872 |
|
|
2017
Q2 | $286K | Buy |
+46,600
| New | +$286K | ﹤0.01% | 2009 |
|